Accipio detects brain haemorrhages, receives FDA 510 (k) Clearance


MaxQ AI (formerly MedyMatch, Tel Aviv, Israel) received the FDA 510 (k) marketing authorization for Accipio, an artificial intelligence software that can quickly detect brain haemorrhage in the CT scan.

The medical device for the software is designed to be acutely sensitive to the presence of intracranial haemorrhage during examination and alert the doctor who is being treated when the bleeding is detected. The tool could help relieve physicians and providers of emergency health services with large numbers, which would allow the rapid diagnosis of patients most needed.

The ability of Accipio to detect suspected brain haemorrhage is so rapid. The potential impact is huge: saving only one patient from an acute stroke in 13,000 hospitals in the US and Europe would save billions of dollars of savings in one year.

There are also plans to use the software in mobile units of the drops. This would allow staff to distinguish between ischemic and hemorrhagic strokes and the administration of a medicament to dissolve blood cells in a patient during transportation to a hospital.

Sources: Mobihealthnews, November 12, 2018.

Source link